Jean Bennett

Insider Reports History

Location
Rockville, MD
Signature
/s/ Patrick J. Christmas as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jean Bennett:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Opus Genetics, Inc. Director Common Stock 214K $190K $0.89 30 Apr 2025 Direct
REGENXBIO Inc. Director Common Stock 19.1K $152K $7.97 30 May 2025 Direct
Opus Genetics, Inc. Director Stock Option (Right to Buy) 79.6K 30 Apr 2025 Direct
REGENXBIO Inc. Director Stock Options (Right to Buy) 39.8K 30 May 2025 Direct
REGENXBIO Inc. Director Stock Options (Right to Buy) 24.5K 31 May 2024 Direct

Insider Reports Filed by Jean Bennett

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RGNX REGENXBIO Inc. 30 May 2025 2 $0 4 Director 03 Jun 2025, 16:31
IRD Opus Genetics, Inc. 30 Apr 2025 2 $0 4 Director 02 May 2025, 17:03
IRD Opus Genetics, Inc. 02 Jan 2025 1 $0 4 Director 06 Jan 2025, 16:42
IRD Opus Genetics, Inc. 22 Oct 2024 2 $0 4 Director 24 Oct 2024, 17:56
IRD Opus Genetics, Inc. 22 Oct 2024 0 $0 3 Director 24 Oct 2024, 17:49
RGNX REGENXBIO Inc. 31 May 2024 2 $0 4 Director 04 Jun 2024, 16:41
RGNX REGENXBIO Inc. 02 Jun 2023 2 $0 4 Director 06 Jun 2023, 17:11
RGNX REGENXBIO Inc. 03 Jun 2022 2 $0 4 Director 07 Jun 2022, 16:16
RGNX REGENXBIO Inc. 03 Sep 2021 1 $0 4 Director 08 Sep 2021, 16:20
RGNX REGENXBIO Inc. 03 Sep 2021 0 $0 3 Director 08 Sep 2021, 16:12